Your browser doesn't support javascript.
loading
Final 5-year findings from the phase 3 HELIOS study of ibrutinib plus bendamustine and rituximab in patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma.
Fraser, Graeme A M; Chanan-Khan, Asher; Demirkan, Fatih; Santucci Silva, Rodrigo; Grosicki, Sebastian; Janssens, Ann; Mayer, Jiri; Bartlett, Nancy L; Dilhuydy, Marie-Sarah; Loscertales, Javier; Avigdor, Abraham; Rule, Simon; Samoilova, Olga; Pavlovsky, Miguel A; Goy, Andre; Mato, Anthony; Hallek, Michael; Salman, Mariya; Tamegnon, Monelle; Sun, Steven; Connor, Anne; Nottage, Kerri; Schuier, Natasha; Balasubramanian, Sriram; Howes, Angela; Cramer, Paula.
Affiliation
  • Fraser GAM; Juravinski Cancer Centre, McMaster University, Hamilton, Canada.
  • Chanan-Khan A; Division of Hematology, Mayo Clinic Cancer Center, Jacksonville, FL, USA.
  • Demirkan F; Division of Hematology, Dokuz Eylul University, Izmir, Turkey.
  • Santucci Silva R; IEP São Lucas/Hemomed Oncologia e Hematologia, São Paulo, Brazil.
  • Grosicki S; Department of Hematology and Cancer Prevention, School of Public Health, Silesian Medical University, Katowice, Poland.
  • Janssens A; Universitaire Ziekenhuizen Leuven, Leuven, Belgium.
  • Mayer J; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Jihlavska, Brno, Czech Republic.
  • Bartlett NL; Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, USA.
  • Dilhuydy MS; Hopital Haut Leveque, Bordeaux, France.
  • Loscertales J; Hematology Department, Hospital Universitario La Princesa, IIS-IP, Madrid, Spain.
  • Avigdor A; Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-Hashomer and Sackler School of Medicine, University of Tel-Aviv, Tel-Aviv, Israel.
  • Rule S; Department of Haematology, University of Plymouth Medical School, Plymouth, UK.
  • Samoilova O; Nizhny Novogorod Regional Clinical Hospital, Nizhny Novogorod, Russia.
  • Pavlovsky MA; Department of Hematology, Fundaleu, Buenos Aires, Argentina.
  • Goy A; John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ, USA.
  • Mato A; Memorial Sloan-Kettering Cancer Center, NY, USA.
  • Hallek M; Department I of Internal Medicine and German CLL Study Group, University of Cologne, Faculty of Medicine and University Hospital of Cologne, Cologne, Germany.
  • Salman M; Janssen Research & Development, Raritan, NJ, USA.
  • Tamegnon M; Janssen Research & Development, Raritan, NJ, USA.
  • Sun S; Janssen Research & Development, Raritan, NJ, USA.
  • Connor A; Janssen Research & Development, Spring House, PA, USA.
  • Nottage K; Janssen Research & Development, Raritan, NJ, USA.
  • Schuier N; Janssen-Cilag, Neuss, Germany.
  • Balasubramanian S; Janssen Research & Development, Spring House, PA, USA.
  • Howes A; Janssen Research & Development, High Wycombe, UK.
  • Cramer P; Department I of Internal Medicine and German CLL Study Group, University of Cologne, Faculty of Medicine and University Hospital of Cologne, Cologne, Germany.
Leuk Lymphoma ; 61(13): 3188-3197, 2020 12.
Article in En | MEDLINE | ID: mdl-32762271
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Lymphocytic, Chronic, B-Cell Type of study: Clinical_trials / Diagnostic_studies Limits: Humans Language: En Journal: Leuk Lymphoma Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2020 Type: Article Affiliation country: Canada
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Lymphocytic, Chronic, B-Cell Type of study: Clinical_trials / Diagnostic_studies Limits: Humans Language: En Journal: Leuk Lymphoma Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2020 Type: Article Affiliation country: Canada